## Definition
Healthcare Common Procedure Coding System (HCPCS) code C8920 refers to “Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral.” This code is used specifically for the diagnostic imaging of one breast, involving both an initial magnetic resonance imaging (MRI) scan without contrast, followed by a second scan administered with contrast material. The purpose of the contrast is to improve the visualization of tissues and potential abnormalities that may not be clearly visible on the non-contrast scan.
This code falls under the broader category of temporary HCPCS codes for outpatient prospective payment system (OPPS) use. In particular, it applies to hospital outpatient departments when billing for diagnostic services provided to Medicare beneficiaries. Providers should be aware that it is used strictly in the outpatient setting under these guidelines.
## Clinical Context
C8920 is commonly utilized in the diagnostic workup of breast cancer, particularly in the evaluation of suspicious lesions identified via mammography or ultrasound. It can also be employed in screening high-risk patients, where enhanced imaging is needed to assess abnormalities not easily detected by standard imaging modalities. Additionally, magnetic resonance imaging (MRI) of the breast may be ordered when patients have dense breast tissue, which can obscure findings in other types of imaging.
The inclusion of contrast material, such as gadolinium, is crucial in increasing the sensitivity of the procedure, allowing radiologists to more precisely differentiate between benign and malignant findings. Moreover, C8920 is typically part of a larger diagnostic pathway, which may include biopsy or other follow-up procedures if the imaging reveals abnormalities of clinical concern.
## Common Modifiers
Modifiers are frequently appended to HCPCS code C8920 to indicate certain billing situations or patient-specific factors that affect the reimbursement. Modifier 26, for example, is often used to denote the professional component when a radiologist interprets the imaging results without directly performing the procedure. Conversely, modifier TC may be deployed to indicate the technical component, which covers the expense of the equipment, facilities, and operation by trained staff.
Another common modifier is modifier RT (right side) or LT (left side), used for specifying which breast is being imaged in a unilateral breast MRI. It is important for accurate documentation and billing that the appropriate anatomical modifiers are appended when invoicing for C8920 to prevent claim rejections or delays in payment.
## Documentation Requirements
Complete and accurate documentation is crucial when billing for C8920 due to the specificity of the imaging procedure. Adequate documentation entails a physician’s order specifying the necessity for imaging, particularly the decision to perform the scan both with and without contrast. The patient’s medical history, including prior imaging findings or clinical suspicion of breast pathology, should also be documented to justify the use of this advanced diagnostic method.
The radiology report must include a description of both the non-contrast and contrast-enhanced imaging results, as well as a final interpretation by the radiologist. Lastly, any observed abnormalities, comparisons to prior imaging studies, and recommendations for further diagnostic actions need to be incorporated into the report to ensure clarity and accuracy.
## Common Denial Reasons
One common reason for claim denials related to HCPCS code C8920 is the lack of medical necessity. Payers may reject claims if the documentation does not sufficiently justify why both non-contrast and contrast-enhanced imaging are required for the patient. To mitigate this, referring physicians should ensure that their clinical rationale for the study is clearly documented.
Another cause for denial is improper use of modifiers. The absence of necessary anatomical or professional/technical component modifiers can result in the claim being flagged for incomplete or incorrect billing. Additionally, failure to obtain the appropriate prior authorization from insurance companies is a frequent issue that can lead to denials, particularly with commercial payers.
## Special Considerations for Commercial Insurers
Commercial insurers may have varied policies regarding reimbursement and coverage for C8920. Unlike Medicare, which follows specific guidelines for outpatient prospective payment system claims, private insurers might require prior authorization before approving breast MRI with contrast. Therefore, it is incumbent upon the provider to check the payer’s requirements specific to the patient’s health plan to avoid denials.
Another special consideration is the frequency limitation imposed by some commercial plans. Certain insurers may limit the number of breast MRIs a patient can receive within a specific timeframe, even when medically justified, making it essential for clinicians to include thorough details in the medical record to support the necessity of multiple imaging studies over time.
## Similar Codes
Several codes within the HCPCS and Current Procedural Terminology (CPT) coding systems bear similarity to C8920 but differ in scope or application. For example, CPT code 77049 refers to “Magnetic resonance imaging, breast, bilateral, with and without contrast,” which is distinct from C8920’s unilateral designation. The use of CPT 77049 occurs when both breasts are imaged during the same session instead of just one.
Another related code is C8908, which describes “Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral.” C8908 should be selected in cases where both breasts are being imaged in the same session and the protocol includes both non-contrast and contrast-enhanced imaging. Similarly, CPT 77058, a predecessor to these codes, primarily covers breast MRI without specific reference to contrast use, thereby missing some of the specificity of C8920.